Page last updated: 2024-10-24

cefuroxime and Mycoplasma dispar Infection

cefuroxime has been researched along with Mycoplasma dispar Infection in 2 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
" The clinical picture of a "typical" bacterial pneumonia in the three patients led to an initial empirical treatment with amoxicillin clavulanic acid or 2(nd) generation cephalosporins."3.69Severe community-acquired pneumonia caused by atypical organisms. ( Huyghens, L; Lauwers, S; Meysman, M; Monsieur, I; Vincken, W, 1997)
"Mycoplasma pneumoniae was identified in 12 patients out of 279 (4."1.37[Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna]. ( Göpfrich, H; Kurz, H, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurz, H1
Göpfrich, H1
Monsieur, I1
Meysman, M1
Vincken, W1
Huyghens, L1
Lauwers, S1

Other Studies

2 other studies available for cefuroxime and Mycoplasma dispar Infection

ArticleYear
[Epidemiology and morbidity of mycoplasma as causative agent for community-acquired pneumonia in hospitalized children in a Community Hospital in Vienna].
    Wiener medizinische Wochenschrift (1946), 2011, Volume: 161, Issue:7-8

    Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Austria; C-Reactive Protein; Cefuroxime; Ch

2011
Severe community-acquired pneumonia caused by atypical organisms.
    Acta clinica Belgica, 1997, Volume: 52, Issue:2

    Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxime

1997